e-learning
resources
Berlin 2001
Monday 24.09.2001
Lung cancer biology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Peculiarities of IGF family in the lung cancer
G. E. Sagindikova, E. A. Kogan, G. Jaques (Moscow, Russia; Marburg, Germany)
Source:
Annual Congress 2001 - Lung cancer biology
Session:
Lung cancer biology
Session type:
Thematic Poster Session
Number:
1603
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. E. Sagindikova, E. A. Kogan, G. Jaques (Moscow, Russia; Marburg, Germany). Peculiarities of IGF family in the lung cancer. Eur Respir J 2001; 16: Suppl. 31, 1603
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Lung cancer and family history of cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 124s
Year: 2006
Prognostic role of epidermal growth factor receptor in stage III nonsmall cell lung cancer
Source: Eur Respir J 2005; 25: 329-335
Year: 2005
Prognostic significance of epidermal growth factor receptor expression in nonsmall cell lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 72s
Year: 2002
Clinical features associated with epidermal growth factor receptor and K-RAS gene mutations in non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 811s
Year: 2006
Expression of sex hormone receptors in non-small cell lung cancer patients
Source: Eur Respir J 2004; 24: Suppl. 48, 79s
Year: 2004
The challenge of targeting EGFR: experience with gefitinib in nonsmall cell lung cancer
Source: Eur Respir Rev 2010 19: 186-196
Year: 2010
Epidermal growth factor receptor and related biomarkers evaluated by immunohistochemistry in patients with resected non-small cell lung cancer
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013
Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer
Source: Eur Respir J 2007; 30: Suppl. 51, 669s
Year: 2007
Epidermal growth factor receptor (EGFR) expression in non-small cell lung carcinoma (NSCLC) and survival
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015
Epidermal growth factor receptor (EGFR) expression in operable non-small cell lung cancer and its correlation with survival
Source: Annual Congress 2009 - Genetics in the smokers corner: from inflammation in smokers via COPD to cancer
Year: 2009
PP138 – Regulation of PA200 in lung cancer
Source: ERS Lung Science Conference 2021
Year: 2021
Regulation of PA200 in lung cancer
Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Year: 2021
Genetic profiling and epidermal growth factor receptor-directed therapy in nonsmall cell lung cancer
Source: Eur Respir J 2011; 37: 183-193
Year: 2011
Epidermal growth factor receptor mutation status in advanced non-small cell lung cancer: A single institution experience
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012
Diverse effects of PAI-1 proteins on lung and prostate cancer cell invasion
Source: Annual Congress 2011 - Lung development and neoplasia
Year: 2011
Relationship between Cancer-associated fibroblast and programmed death ligand 1 expression in non-small cell lung cancer
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020
Epigenetics and lung cancer
Source: Annual Congress 2006 - Epigenetics and respiratory disease
Year: 2006
Importance of clusterin expression at tissue level for the prognosis of non-small cells lung cancer
Source: Annual Congress 2009 - Lung cancer biology
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept